Search Results - "Rieger, Angela C."

A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration by Natsumeda, Makoto, Florea, Victoria, Rieger, Angela C., Tompkins, Bryon A., Banerjee, Monisha N., Golpanian, Samuel, Fritsch, Julia, Landin, Ana Marie, Kashikar, Nilesh D., Karantalis, Vasileios, Loescher, Viky Y., Hatzistergos, Kostas E., Bagno, Luiza, Sanina, Cristina, Mushtaq, Muzammil, Rodriguez, Jose, Rosado, Marcos, Wolf, Ariel, Collon, Kevin, Vincent, Louis, Kanelidis, Anthony J., Schulman, Ivonne H., Mitrani, Raul, Heldman, Alan W., Balkan, Wayne, Hare, Joshua M.

“…The combination of autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CSCs) synergistically reduces scar size and improves cardiac function in…”
Get full text

Clinical-based Cell Therapies for Heart Disease-Current and Future State by Turner, Darren, Rieger, Angela C, Balkan, Wayne, Hare, Joshua M

“…Patients have an ongoing unmet need for effective therapies that reverse the cellular and functional damage associated with heart damage and disease. The…”
Get full text

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy by Tompkins, Bryon A, Rieger, Angela C, Florea, Victoria, Banerjee, Monisha N, Natsumeda, Makoto, Nigh, Evan D, Landin, Ana Marie, Rodriguez, Gianna M, Hatzistergos, Konstantinos E, Schulman, Ivonne Hernandez, Hare, Joshua M

“…Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem…”
Get full text

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy by Rieger, Angela C., Myerburg, Robert J., Florea, Victoria, Tompkins, Bryon A., Natsumeda, Makoto, Premer, Courtney, Khan, Aisha, Schulman, Ivonne H., Vidro-Casiano, Mayra, DiFede, Darcy L., Heldman, Alan W., Mitrani, Raul, Hare, Joshua M.

“…Non-ischemic dilated cardiomyopathy (NIDCM) responds variably to intramyocardial injection of mesenchymal stem cells (MSCs). We hypothesized that NIDCM…”
Get full text

Non-oncologic incidental uptake on FAPI PET/CT imaging by Hotta, Masatoshi, Rieger, Angela C, Jafarvand, Mahbod G, Menon, Nandakumar, Farolfi, Andrea, Benz, Matthias R, Calais, Jeremie

“…Fibroblast-activation protein (FAP) is a serine protease classified in the dipeptidyl peptidase 4 (DPP4) family. FAP is predominantly expressed in activated…”
Get full text

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial by Hare, Joshua M, DiFede, Darcy L, Rieger, Angela C, Florea, Victoria, Landin, Ana M, El-Khorazaty, Jill, Khan, Aisha, Mushtaq, Muzammil, Lowery, Maureen H, Byrnes, John J, Hendel, Robert C, Cohen, Mauricio G, Alfonso, Carlos E, Valasaki, Krystalenia, Pujol, Marietsy V, Golpanian, Samuel, Ghersin, Eduard, Fishman, Joel E, Pattany, Pradip, Gomes, Samirah A, Delgado, Cindy, Miki, Roberto, Abuzeid, Fouad, Vidro-Casiano, Mayra, Premer, Courtney, Medina, Audrey, Porras, Valeria, Hatzistergos, Konstantinos E, Anderson, Erica, Mendizabal, Adam, Mitrani, Raul, Heldman, Alan W

“…Although human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist in chronic nonischemic dilated cardiomyopathy…”
Get full text

Attenuation of frailty in older adults with mesenchymal stem cells by Florea, Victoria, Bagno, Luiza, Rieger, Angela C., Hare, Joshua M.

“…•Frailty is a syndrome characterized by exhaustion, weight loss, a feeling of slowing down, and low levels of activity.•Frailty is associated with chronic…”
Get full text

Reply: Posterior Cingulate Involvement Does Not Argue Against LATE—And Who Said It Does? by Rieger, Angela C., Silverman, Daniel H.S.

Get full text

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study) by Florea, Victoria, Rieger, Angela C, DiFede, Darcy L, El-Khorazaty, Jill, Natsumeda, Makoto, Banerjee, Monisha N, Tompkins, Bryon A, Khan, Aisha, Schulman, Ivonne H, Landin, Ana Marie, Mushtaq, Muzammil, Golpanian, Samuel, Lowery, Maureen H, Byrnes, John J, Hendel, Robert C, Cohen, Mauricio G, Valasaki, Krystalenia, Pujol, Marietsy V, Ghersin, Eduard, Miki, Roberto, Delgado, Cindy, Abuzeid, Fouad, Vidro-Casiano, Mayra, Saltzman, Russell G, DaFonseca, Daniel, Caceres, Lina V, Ramdas, Kevin N, Mendizabal, Adam, Heldman, Alan W, Mitrani, Raul D, Hare, Joshua M

“…Cell dose and concentration play crucial roles in phenotypic responses to cell-based therapy for heart failure. To compare the safety and efficacy of 2 doses…”
Get full text

Is It Too Soon to Know When It's LATE? by Rieger, Angela C, Silverman, Daniel H S

Get full text

The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy by Florea, Victoria, Rieger, Angela C, Natsumeda, Makoto, Tompkins, Bryon A, Banerjee, Monisha N, Schulman, Ivonne H, Premer, Courtney, Khan, Aisha, Valasaki, Krystalenia, Heidecker, Bettina, Mantero, Alejandro, Balkan, Wayne, Mitrani, Raul D, Hare, Joshua M

“…Abstract Aims Sex differences impact the occurrence, presentation, prognosis, and response to therapy in heart disease. Particularly, the phenotypic…”
Get full text

Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction by Rieger, Angela C., Bagno, Luiza L., Salerno, Alessandro, Florea, Victoria, Rodriguez, Jose, Rosado, Marcos, Turner, Darren, Dulce, Raul A., Takeuchi, Lauro M., Kanashiro-Takeuchi, Rosemeire M., Buchwald, Peter, Wanschel, Amarylis C. B. A., Balkan, Wayne, Schulman, Ivonne H., Schally, Andrew V., Hare, Joshua M.

“…Therapies for heart failure with preserved ejection fraction (HFpEF) are lacking. Growth hormone-releasing hormone agonists (GHRH-As) have salutary effects in…”
Get full text

New insights into cell‐based therapy for heart failure from the CHART‐1 study by Tompkins, Bryon A., Rieger, Angela C., Florea, Victoria, Banerjee, Monisha N., Hare, Joshua M.

Get full text

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction by Rieger, Angela C, Tompkins, Bryon A, Natsumeda, Makoto, Florea, Victoria, Banerjee, Monisha N, Rodriguez, Jose, Rosado, Marcos, Porras, Valeria, Valasaki, Krystalenia, Takeuchi, Lauro M, Collon, Kevin, Desai, Sohil, Bellio, Michael A, Khan, Aisha, Kashikar, Nilesh D, Landin, Ana Marie, Hardin, Darrell V, Rodriguez, Daniel A, Balkan, Wayne, Hare, Joshua M, Schulman, Ivonne Hernandez

“…Left ventricular hypertrophy and heart failure with preserved ejection fraction (HFpEF) are primary manifestations of the cardiorenal syndrome in patients with…”
Get full text

Abstract 35: Transendocardial Mesenchymal Stem Cell Injection Demonstrates Reverse Remodeling Effects of Global LV Volumes and Enhanced Lateral Papillary Muscle Shortening by Vincent, Louis, Natsumeda, Makoto, Rieger, Angela C, Florea, Victoria, Tompkins, Bryon A, Balkan, Wayne, Leroux, Lionel, Hare, Joshua M

“…Abstract only Rationale: Secondary mitral regurgitation (MR) carries a poor prognosis despite improvements in surgical and transcatheter interventions…”
Get full text

Abstract 16707: Human Embryonic Stem Cell-Derived Cardiomyocytes Are Safe and Improve Infarct Size and Cardiac Function in a Porcine Model of Myocardial Infarction by Banerjee, Monisha N, Bagno, Luiza, Florea, Victoria, Rieger, Angela C, Mitrani, Raul, Rodriguez, Jose, Rosado, Marcos, Sanchez, Jennifer, Desai, Sohil S, Alvarez, Alexandra L, Chase, Ren, Khan, Aisha, Balkan, Wayne, Neofytou, Evgenios, Wu, Joseph C, Hare, Joshua M

“…IntroductionStem cell therapy is an emerging means of stimulating cardiac repair after myocardial infarction (MI). Human embryonic stem cell-derived…”
Get full text

Abstract 33: Combination of Allogeneic Mesenchymal and Kidney-derived Stem Cells Promotes Kidney Repair in a Swine Model of Chronic Kidney Disease by Rieger, Angela C, Tompkins, Bryon A, Natsumeda, Makoto, Florea, Victoria, Rodriguez, Jose, Rosado, Marcus, Balkan, Wayne, Hare, Joshua M, Schulman, Ivonne H

“…Abstract only Background: Chronic kidney disease (CKD) has a high prevalence (~14% of the population) and is associated with a significantly increased risk of…”
Get full text

Ischemic vs. Non-Ischemic Dilated Cardiomyopathy: a Comparative Study in Stem Cell Therapy Efficacy by Tompkins, Bryon A., Rieger, Angela C., Florea, Victoria, Natsumeda, Makoto, Nigh, Evan D., Landin, Ana Marie, Rodriguez, Gianna M., Hatzistergos, Konstantinos E., Schulman, Ivonne H., Hare, Joshua M.

Get full text

Do Males and Females with Non-Ischemic Dilated Cardiomyopathy Respond Similarly to Stem Cell Therapy? an Analysis From the POSEIDON-DCM Trial by Florea, Victoria, Rieger, Angela C., Natsumeda, Makoto, Tompkins, Bryon A., Landin, Ana M., Premer, Courtney, DiFede, Darcy L., Balkan, Wayne, Schulman, Ivonne H., Hare, Joshua M.

Get full text

177 - Do Males and Females with Non-Ischemic Dilated Cardiomyopathy Respond Similarly to Stem Cell Therapy? an Analysis From the POSEIDON-DCM Trial by Florea, Victoria, Rieger, Angela C., Natsumeda, Makoto, Tompkins, Bryon A., Landin, Ana M., Premer, Courtney, DiFede, Darcy L., Balkan, Wayne, Schulman, Ivonne H., Hare, Joshua M.

Get full text